Rituximab (Arm B)

DRUG3 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Ostfold Hospital Trust, Angelica Lindén Hirschberg

Conditions

Autoimmune Prematur Ovarian InsuffienceGranulomatosis With PolyangiitisMicroscopic PolyangiitisRenal Limited FormsThrombocytopenia Purpura

Phase 3

Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis

CompletedNCT01731561

Assistance Publique - Hôpitaux de ParisGranulomatosis With Polyangiitis, Microscopic Polyangiitis, Renal Limited Forms

Start: 2012-11-16End: 2016-04-05Updated: 2025-09-05

The Holistic Study

Not yet recruitingNCT07051915

Ostfold Hospital TrustThrombocytopenia Purpura

Start: 2025-09-15End: 2029-12-31Target: 220Updated: 2025-09-09

Immunomodulatory Therapy to Restore Ovarian Function and Improve Fertility in Women With Autoimmune Premature Ovarian Insufficiency

RecruitingNCT07509840

Angelica Lindén HirschbergAutoimmune Prematur Ovarian Insuffience

Start: 2026-02-12End: 2031-12-31Target: 40Updated: 2026-04-03

Related Papers

The holistic trial: A comprehensive evaluation of two second-line therapeutic approaches for immune thrombocytopenia (ITP) – a pragmatic randomized controlled trial

Blood2025-11-03

Association Between Plasma Rituximab Concentration and the Risk of Major Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides During Rituximab Maintenance Therapy

Arthritis & Rheumatology2023-05-039 citations

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

2018-04-25209 citations